Larisa Vorobyeva, MD
Obstetrics & Gynecology · Brooklyn, NYNPI 1194971069
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 98.0% of the total across 60 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 16 manufacturers, the largest accounting for just 17.0% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $240, 4.3 times the $56 reported in 2019.
Across 60 payments — averaging $19.80 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Avion Pharmaceuticals$202
- AbbVie$181
- Exeltis, USA Inc.$165
- Shield Therapeutics Inc$155
- Hologic Sales And Service, LLC$145
- Mayne Pharma Commercial LLC$73
- plus $266 from 10 others
What the payments were for
- Food & beverage$1,16498%
- Education$242%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Avion Pharmaceuticals | 14 | $202 |
| AbbVie | 9 | $181 |
| Exeltis, USA Inc. | 9 | $165 |
| Shield Therapeutics Inc | 7 | $155 |
| Hologic Sales And Service, LLC | 1 | $145 |
| Mayne Pharma Commercial LLC | 7 | $73 |
| Coopersurgical, Inc. | 2 | $47 |
| Myovant Sciences Inc. | 2 | $38 |
| Biohaven Pharmaceutical Holding Company Ltd. | 2 | $31 |
| Sumitomo Pharma America, Inc. | 1 | $25 |
| AMAG Pharmaceuticals, Inc. | 1 | $24 |
| Millicent US Inc | 1 | $24 |
| Lupin Inc. | 1 | $21 |
| BD | 1 | $21 |
| Astellas Pharma US Inc | 1 | $20 |
| Pfizer | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$1,188 in reported general payments places this provider in the 70th percentile of 2,673 obstetrics & gynecology providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Metronidazole | 41 | $2,880 |
| Estradiol | 27 | $2,668 |
| Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip | 47 | $902 |
| Clobetasol Propionate | 14 | $887 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 69 | $506 |
| ValacyclovirValacyclovir Hcl | 15 | $193 |
| Cefdinir | 14 | $66 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 52 | $47 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 11 | $41 |
Paid to pharmacies, not to this prescriber.
Other obstetrics & gynecology in Brooklyn
- Miriam CremerBrooklyn$196K
- Michael LewisBrooklyn$62K
- Kathleen MorrellBrooklyn$48K
- Mark DefazioBrooklyn$27K
- Mary PolanNew York$862K
- Steven GoldsteinNew York$551K
- Veronica LernerNew York$368K
- Lisa EngNew York$219K
- Theodore GoldmanEast Northport$213K
- Rachel MaschNew York$187K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.